Nutraceutical (Medicinal Mushrooms) products for a wide variety of ailments. An ideal organic and alternative solution for the African market.
We offer a wide range of nutritional supplements such as Bamboo Silica, along with a good number of quality approved nutraceutal non-medicinal mushrooms.
Over The Counter (OTC) Drugs. We offer a selection of drugs such as Ibuprofen, Folic acid, and Vitamin products that are needed in Africa.
Through our efficient and locally approved procuremnt standards, we are able to deliver much needed prescription medication to the African market.
Making a difference in Africa
BGiL Pharma is a Pharmaceutical Wholesale Distributor that delivers Over-The-Counter (OTC), nutritional supplements as well as prescription only medicines(POM) to emerging and resource limited economies in Africa. The reputation of BGiL Pharma on the African continent is built on honest, dependable relationships our satellite distributors have developed with clients.
BGiL Pharma has established business ties with local distributors in several African countries, whose vision for a healthier Africa mimics that of BGiL Pharma. Our local partners have an excellent mastery of their local markets and provide exceptional assistance to our consumers.
With a seasoned team of experienced and committed representatives, BGI Pharma has the ability to reach every country and every major city on the African continent and is familiar with the convoluted logistic difficulties faced by most African countries. The service we provide to our clientele is based on a thorough understanding of systems and processes on the African continent.
"For low and middle income African countries to make positive strides at reducing health care costs, disease prevention rather than treatment must be the target objective. The urgent need for health authorities in Africa to raise awareness that people are better off staying healthy rather than relying on far fetched sophisticated medical technology to rescue them from a lifetime of unhealthy living can hardly be overemphasized".
S. A.Chiambah, RPh. | BGiL Pharma
"Dear BGiL Pharma….your arrival on the African pharmaceutical platform is long overdue. Close to 100,000 deaths in Africa have been attributed to counterfeit drug sales according to the World Health Organisation (WHO). This number is at best a very conservative figure. Fake or adulterated anti-bacterial, anti-malarial and anti-tuberculosis drugs in particular have the potential to select for resistant pathogens that they should otherwise be eliminating. The thought of such occurrences becoming widespread is very worrying given the very rudimentary resources available for tracking drug resistant pathogens in limited resource settings"DR JESSIE BWANALI, PHD
"Traditional evidence based medicine has focused research and invested heavily on how to improve life expectancy very often at the expense of Quality of Life. To paraphrase one of the fathers of modern British medicine, Lord Hutchison, they have made the cure for these diseases more grievous to bear than the endurance of the same. In so doing they have opened a large gab in the medicine market. Only Nutritional Science can fill this large medicine gap because it is based on common sense. BGiL Pharma is timely, a most welcome idea for Africa and is ensuring we are not left behind in this all important era of The Medicines."DR RAYMOND ASONGWE, MD
"BGIL Pharma is a sure need for a great continent, providing excellent and high quality products to establishments in Africa. I would have no hesitation recommending its services to any government and private enterprise in Africa as well as individuals for carefully sourced pharmaceutical products. The variety of high end products offered and the ability to match competitive rates makes BGIL an establishment that would enhance drug safety. I am delighted that Africa would benefit from BGIL and commend all its effort to improve health and life"MRS ELOZONA UZOEGWU-UMEH
Articles & Updates
The vast majority of patients believe that pharmaceutical companies should provide services that complement the products they provide, whether they are taking long-term, short-term or lifestyle medications, a new US study has found.
New research suggests that physical activity might protect our eyes as we age. There have been suggestions that exercise might reduce the risk of macular degeneration, which occurs when neurons in the central part of the retina deteriorate.
The International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization, Launched the World Cancer Report 2014 in February of last year.
Good health is wealth. Besides the fact that there's an intrinsic value of health that is a human right, the economic case for investing in healthcare is robust. Experts agree that improved healthcare in Africa is essential for sustainable development. Healthier citizens are more productive, earn more, consume more, work longer, all of which have a positive impact on the Gross Domestic Product of a country. Better health also reduces the financial cost of healthcare for the family, the community, the private sector and the government.
According to consultancy firm – McKinsey, by 2016 the market for health care in Sub-Saharan Africa will be worth $35 billion, however a skills shortage is constraining it since the continent is reckoned to host a quarter of the world's disease burden but only has 3% of its medical workforce. The World Bank reckons an additional 90,000 doctors and 500,000 nurses will be needed in the next few years. The private sector has a positive role to play within the broader context of Sub-Saharan African countries health care systems by expanding access and improving quality and efficiency.